CTOs on the Move

Katahdin Industries

www.katahdin-inc.com

 
Katahdin Industries provides high-tolerance coating applications and specialized metal-finishing technology and services to the medical device and industrial markets through platform-focused subsidiaries including DCHN, Precision Coating, Medi-Solve Coatings and Sanford Process. Headquartered in Dedham, Mass., with operations in Woonsocket, R.I., Katahdin has earned an industry reputation as an innovative, high-quality supplier. Katahdin's technical and product development expertise, strong facilities and problem-solving culture have resulted in a track record of successful service performance for its customers. Each subsidiary is an expert provider of the services it offers. But mastery of the technology is only part of our competitive differentiation. Developing unique capabilities to ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

R and M Distributing

R and M Distributing is a Brookfield, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medicom

Medicom is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Surgical Acuity Inc

Surgical Acuity Inc is a Middleton, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tearlab

TearLab Corporation develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation`s common shares trade on the NASDAQ Capital Market under the symbol `TEAR` and on the Toronto Stock Exchange under the symbol `TLB`. Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley’s Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagnosed with the disease. Millions more suffer worldwide. The TearLab™ Osmolarity System provides the first quantitative and objective diagnostic technology that allows doctors to effectively manage their dry eye patients. TearLab will allow practitioners to diagnosis DED patients early in the disease process allowing for early intervention. TearLab received the CE Mark for its TearLab Osmolarity System in 2008 and FDA Clearance in 2009. TearLab is currently marketed globally in more than 14 countries including the US.

Greatbatch

Greatbatch, Inc. provides top-quality technologies to industries that depend on reliable, long-lasting performance through its brands Greatbatch Medical, Electrochem and QiG Group.